Thiago Carvalho on Nostr: 'In this randomized, controlled trial involving women in South Africa and Uganda, ...
'In this randomized, controlled trial involving women in South Africa and Uganda, twice-yearly subcutaneous lenacapavir was superior to daily oral emtricitabine–tenofovir disoproxil fumarate in preventing HIV infection.'
https://www.nejm.orgPublished at
2024-10-04 06:13:25Event JSON
{
"id": "360b15541f9c1b9602c952bfe4f4e2770ca1a79e3cc83444eadb43821783fd7a",
"pubkey": "376d961fc946cb96839a4d257809dc9e6d237e2d0cc158199b8cc5c5771939a6",
"created_at": 1728022405,
"kind": 1,
"tags": [
[
"proxy",
"https://qoto.org/users/cyrilpedia/statuses/113247676387945511",
"activitypub"
]
],
"content": "'In this randomized, controlled trial involving women in South Africa and Uganda, twice-yearly subcutaneous lenacapavir was superior to daily oral emtricitabine–tenofovir disoproxil fumarate in preventing HIV infection.'\n\nhttps://www.nejm.org",
"sig": "886cbbd24b4fd2ec6272ab96534955f3d18f03f293de2d38f188dfa08ed673f4610bb59db8662b480897b749ed40a92206f050ff975908fbfebba62bf9d2f3b1"
}
